# Maternal Flu Vaccine Trial in Bamako, Mali

> **NCT01430689** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 4193 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza Vaccine Trivalent Types A and B
- **BIOLOGICAL:** Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine

## Key facts

- **NCT ID:** NCT01430689
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 4193 (ACTUAL)
- **Last updated:** 2019-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430689, "Maternal Flu Vaccine Trial in Bamako, Mali". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01430689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*